Đang chuẩn bị liên kết để tải về tài liệu:
Báo cáo y học: "Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation"

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học quốc tế cung cấp cho các bạn kiến thức về ngành y đề tài: Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation | Wu et al. Journal of Biomedical Science 2010 17 88 http www.jbiomedsci.eom content 17 1 88 tì.NSC The cost of publication in Journal of Biomedical Science Is borne by the National Science Council Taiwan JOURNAL OF BIOMEDICAL SCIENCE RESEARCH Open Access Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4 T help and dendritic cell activation Chao-Yi Wu1 Archana Monie1 Xiaowu Pang5 Chien-Fu Hung1 4 T-C Wu1 2 3 4 Abstract Background Effective vaccination against human papillomavirus HPV represents an opportunity to control cervical cancer. Peptide-based vaccines targeting HPV E6 and or E7 antigens while safe will most likely require additional strategies to enhance the vaccine potency. Methods We tested the HPV-16 E7 peptide-based vaccine in combination with a strategy to enhance CD4 T help using a Pan HLA-DR epitope PADRE peptide and a strategy to enhance dendritic cell activation using the toll-like receptor 3 ligand poly I C . Results We observed that mice vaccinated with E7 peptide-based vaccine in combination with PADRE peptide and poly I C generated better E7-specific CD8 T cell immune responses as well as significantly improved therapeutic anti-tumor effects against TC-1 tumors compared to E7 peptide-based vaccine with either PADRE peptide or poly I C alone. Furthermore we found that intratumoral vaccination with the E7 peptide in conjunction with PADRE peptide and poly I C generates a significantly higher frequency of E7-specific CD8 T cells as well as better survival compared to subcutaneous vaccination with the same regimen in treated mice. Conclusions The combination of PADRE peptide and poly I C with antigenic peptide is capable of generating potent antigen-specific CD8 T cell immune responses and antitumor effects in vaccinated mice. Our study has significant clinical implications for peptide-based vaccination. Introduction Cervical cancer is the 2nd leading cause of cancer deaths in women worldwide. The primary etiological factor in

Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.